Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 13, 2019 08:00 ET | Source: Mustang Bio, Inc.

Mustang Bio to Present at the Cell & Gene Therapy USA Congress 2019

NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and...
May 10, 2019 07:30 ET | Source: Mustang Bio, Inc.

Mustang Bio Reports First Quarter 2019 Financial Results and Recent Corporate Highlights

NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and...
May 08, 2019 09:25 ET | Source: Mustang Bio, Inc.

Mustang Bio Announces Full Exercise of Option

NEW YORK, May 08, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and...
May 08, 2019 07:30 ET | Source: Mustang Bio, Inc.

Mustang Bio Announces City of Hope Opens First-of-Its-Kind Multiple Myeloma CAR T Cell Therapy Trial Targeting CS1 Protein

NEW YORK, May 08, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and...
April 30, 2019 10:01 ET | Source: Mustang Bio, Inc.

Mustang Bio Announces Pricing of Public Offering of Common Stock

NEW YORK, April 30, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and...
April 29, 2019 16:01 ET | Source: Mustang Bio, Inc.

Mustang Bio Announces Proposed Public Offering of Common Stock

NEW YORK, April 29, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and...
April 17, 2019 17:01 ET | Source: Mustang Bio, Inc.

St. Jude Children’s Research Hospital publishes results of Lentiviral Gene Therapy for Treatment of Infants with X-linked Severe Combined Immunodeficiency in New England Journal of Medicine

Licensing partnership for vector between St. Jude and Mustang Bio announced in Summer, 2018 This Phase 1/2 trial in newly diagnosed infants with XSCID continues to enroll at St. Jude, UCSF Benioff...
April 09, 2019 08:30 ET | Source: Mustang Bio, Inc.

Mustang Bio to Present at the World Orphan Drug Congress USA 2019

NEW YORK, April 09, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and...
April 01, 2019 09:00 ET | Source: Mustang Bio, Inc.

Mustang Bio Announces $20 Million Venture Debt Financing Agreement with Horizon Technology Finance

NEW YORK, April 01, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and...
March 18, 2019 07:30 ET | Source: Mustang Bio, Inc.

Mustang Bio Reports Full-Year 2018 Financial Results and Recent Corporate Highlights

NEW YORK, March 18, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and...